Goldman Sachs’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $37K | Sell |
|
|||||
|
2017
Q2 | $50K | Sell |
|
|||||
|
2017
Q1 | $123K | Sell |
|
|||||
|
2016
Q4 | $91K | Buy |
|
|||||
|
2016
Q3 | $113K | Sell |
|
|||||
|
2016
Q2 | $182K | Sell |
|
|||||
|
2016
Q1 | $317K | Sell |
|
|||||
|
2015
Q4 | $1.05M | Sell |
|
|||||
|
2015
Q3 | $1.68M | Sell |
|
|||||
|
2015
Q2 | $4.1M | Buy |
|
|||||
|
2015
Q1 | $1.96M | Sell |
|
|||||
|
2014
Q4 | $4.19M | Sell |
|
|||||
|
2014
Q3 | $4.5M | Buy |
|
|||||
|
2014
Q2 | $1.46M | Buy |
|
|||||
|
2014
Q1 | $378K | Sell |
|
|||||
|
2013
Q4 | $576K | Sell |
|
|||||
|
2013
Q3 | $3.26M | Buy |
|
|||||
|
2013
Q2 | $477K | Buy |
|